Diabetes is group of metabolic disorder, often known as diabetes mellitus, marks in high blood glucose levels. Body cells use glucose as a source of energy and insulin is significant for the cells to absorb this glucose. The type 2 diabetes is the most common type and affects over 90% of the global diabetic patients. Diabetes drugs are drugs used by diabetics to maintain the blood glucose levels to restore the blood glucose metabolism to a normal state.
MARKET DYNAMICS
The diabetes drug therapy market is driving due to the rise in geriatric population and increase in prevalence of diabetes worldwide. However, lack of awareness regarding diabetes drug therapy hinders the market's growth. Moreover, rising awareness regarding diabetes care, growing prevalence of obesity are expected to provide opportunities in the global diabetes drug therapy market.
MARKET SCOPE
The "Diabetes Drug Therapy Market Analysis to 2028" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of diabetes drug therapy market with detailed market segmentation by product type and application. The diabetes drug therapy market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in diabetes drug therapy market and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The diabetes drug therapy market is segmented on the basis of product type and application. Based on product type, the market is segmented as glucagon-like peptide-1 (GLP-1) agonist, Dipeptidyl-peptidase-4 (DPP-4) inhibitors, Sodium glucose co-transporter 2 (SGLT2) inhibitors, Insulin, Others. Based on application, the market is segmented as type 1 diabetes, type 2 diabetes, gestational diabetes, impaired glucose tolerance, impaired fasting glycaemia.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Diabetes drug therapy market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The diabetes drug therapy market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting diabetes drug therapy market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Diabetes drug therapy market in these regions.
MARKET PLAYERS
The report covers key developments in the diabetes drug therapy market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Diabetes drug therapy market are anticipated to have lucrative growth opportunities in the future with the rising demand for Diabetes drug therapy in the global market. Below mentioned is the list of few companies engaged in the Diabetes drug therapy market.
The report also includes the profiles of key players in diabetes drug therapy market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Abbott Laboratories
- Mannkind Corporation
- Bristol Myers Squibb
- Medtronic
- AstraZeneca
- Eli Lilly and Company
- GlaxoSmithKline
- Sanofi
- Novo Nordisk
- Novartis International AG
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.